Your Vectra score reveals the severity of your RA, how well your current treatment is working, and is the best predictor of future joint damage. You don’t need to rely on symptoms alone. Vectra can be used to guide treatment decisions and enhanced care.
The scores range from 1-100 with lower scores indicating less RA inflammation and higher scores indicating more inflammation. Patients with Vectra scores in the low range are at a lower risk of future joint damage. Patients in the high and moderate categories are considered to have uncontrolled inflammation and may require treatment modification.
Knowing your risk for joint damage can help you and your doctor assess the treatment plan that’s right for you.
Measure Rheumatoid Arthritis Inflammation
Rheumatoid arthritis (RA) is a complicated disease with symptoms that can vary widely. Vectra reveals the extent of RA inflammation inside your body.
Your Vectra score is personalized for you. Because people tend to have higher or lower levels of inflammation based on their age, gender, and level of body fat, each patient’s score is adjusted to account for these differences. This means that your score accurately reflects the RA inflammation you are experiencing.
Track RA Activity
Multiple Vectra scores can help track your disease activity over time. With repeated use, your Vectra scores reveal how well your current treatment is controlling inflammation.
Insightful and Actionable Results
When the Vectra score goes up or down by 8 or more units, that means your level of RA inflammation has changed. Meaningful changes from one Vectra score to the next can help guide treatment decisions.
Predict Future Joint Damage
Vectra is the best predictor of the risk for developing new damage to your joints. If your Vectra score is in a moderate or high range, your doctor may recommend modifying your treatment plan to try to decrease your risk of future joint damage. An improved response would mean a decrease in your disease activity and also a lower risk of joint damage.
The most comprehensive rheumatoid arthritis assessment combines information from the patient, physician, and molecular results.
Vectra detects what’s going on below the surface by assessing multiple biological pathways that drive RA inflammation. The Vectra molecular result provides information about your RA that goes beyond physical symptoms.
Patients in the high and moderate categories are considered to have uncontrolled inflammation and may require treatment modification.
Vectra measures 12 biomarkers found in your blood that are implicated in rheumatoid arthritis and affect the level of RA inflammation. The scores range from 1-100 with lower scores indicating less RA inflammation and higher scores indicating more. Patients with Vectra scores in the low range are at a low risk of future joint damage, whereas, those in the high or moderate range have an increased risk of joint damage.
Learn more about Vectra and how it can improve patient and provider decisions.